William Guyer

Companies

• Corcept TherapeuticsChief Development Officer Aug 19, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CTCorcept Therapeutics CORT4,313 shares²$475.1K at $110.16Sep 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 1, 2026Granted 164 shares of Corcept Therapeutics²
• Sep 1, 2026Granted 164 shares at $113.38 of Corcept Therapeutics²
• Aug 10, 2026Sold 4,770 shares at $114.04 of Corcept Therapeutics³
• Aug 10, 2026Sold 11,530 shares at $113.18 of Corcept Therapeutics³
• Aug 10, 2026Exercised options 16,300 shares at $21.65 of Corcept Therapeutics³
• Aug 4, 2026Sold 3,700 shares at $113.12 of Corcept Therapeutics⁴
• Aug 4, 2026Exercised options 3,700 shares at $21.65 of Corcept Therapeutics⁴
• Jul 7, 2026Sold 952 shares at $93.54 of Corcept Therapeutics⁵
• Jul 7, 2026Sold 19,048 shares at $93.11 of Corcept Therapeutics⁵
• Jul 7, 2026Exercised options 20,000 shares at $21.65 of Corcept Therapeutics⁵
• Jun 2, 2026Sold 20,000 shares at $70.60 of Corcept Therapeutics⁶
• Jun 2, 2026Exercised options 20,000 shares at $21.65 of Corcept Therapeutics⁶
• Jun 1, 2026Granted 877 shares of Corcept Therapeutics⁷
• Jun 1, 2026Granted 877 shares at $70.44 of Corcept Therapeutics⁷
• May 5, 2026Sold 20,000 shares at $51.83 of Corcept Therapeutics⁸
• May 5, 2026Exercised options 20,000 shares at $21.65 of Corcept Therapeutics⁸
• Apr 7, 2026Sold 20,000 shares at $40.97 of Corcept Therapeutics⁹
• Apr 7, 2026Exercised options 20,000 shares at $21.65 of Corcept Therapeutics⁹
• Mar 20, 2026Sold 11,767 shares at $36.01 of Corcept Therapeutics¹⁰
• Mar 20, 2026Exercised options 11,767 shares at $21.65 of Corcept Therapeutics¹⁰
• Mar 4, 2026Sold 8,233 shares at $35.99 of Corcept Therapeutics¹¹
• Mar 4, 2026Exercised options 8,233 shares at $21.65 of Corcept Therapeutics¹¹
• Mar 2, 2026Granted 498 shares of Corcept Therapeutics¹²
• Mar 2, 2026Granted 498 shares at $35.97 of Corcept Therapeutics¹²
• Feb 3, 2026Sold 20,000 shares at $40.87 of Corcept Therapeutics¹³